RECENT FUNDING
  1. Recent Funding
  2. Investors
  3. Euclidean Capital
E

Euclidean Capital portfolio

Euclidean Capital has 10 portfolio companies on record at Recent Funding, with 1 investment in the last 12 months.

Type: Investor.
Portfolio on Recent Funding: 10.
Deals, last 12 months: 1.
Capital in their rounds: $962.5M.
Latest deal: Setara Biosciences · Oct 30, 2026.
About this page

Its most recent investment on record is Setara Biosciences's $90M Series A round in October 2026, alongside EcoR1 Capital, Jazz Pharmaceuticals, Droia Ventures and 3 others. By category, its portfolio leans toward Health and bio (5) and Sales and marketing (2). It has co-invested with Deerfield, Droia Ventures and Canaan Partners, most often Deerfield (3 rounds).

What Euclidean Capital invests in

Euclidean Capital recent investments

CompanyRoundDateAlongside
SSetara BiosciencesSeries A · $90MEcoR1 Capital, Jazz Pharmaceuticals, Droia Ventures +3
SSavvy WealthSeries B+ · $72MBrewer Lane Ventures, Vamsi Yadlapati, Thrive Capital +5
AActio BiosciencesSeries B+ · $66MDroia Ventures, Regeneron Ventures (lead), Deerfield (lead) +1
NNura BioSeries A · $68MSamsara Biocapital, Sanofi Ventures, The Column Group (lead)
FFundGuardSeries B+ · $100MBlumberg, Union Tech Ventures, Team8 +3
SSion PowerSeries A · $75MHillspire, LG Energy Solution (lead)
AActio BiosciencesSeries A · $55MEcoR1 Capital, Droia Ventures (lead), Deerfield +1
ZZeitviewSeries B+ · $55MHearst Ventures, Upfront Ventures, Valor Equity Partners (lead) +2

How Euclidean Capital invests

StageDealsCapital in rounds
Series B+ 7 64%$674.5M
Series A 4 36%$288M
YearDealsCapital in rounds
2020 2 18%$261.5M
2021 1 9%$120M
2023 2 18%$110M
2024 3 27%$243M
2025 2 18%$138M
2026 1 9%$90M

Euclidean Capital portfolio companies

CompanyRound with Euclidean CapitalTotal raisedLatest raise
SSetara Biosciences
Health and bio
Series A · $90M$90MOct 30, 2026
Series A
SSavvy Wealth
Sales and marketing
Series B+ · $72M$216.8MSep 9, 2026
Series B+
AActio Biosciences
Health and bio
Series B+ · $66M$121MJun 18, 2025
Series B+
NNura Bio
Health and bio
Series A · $68M$141.8MJun 22, 2026
Series B+
FFundGuard
Fintech
Series B+ · $100M$156MMar 25, 2024
Series B+
SSion Power
Climate and energy
Series A · $75M$75MJan 29, 2024
Series A
ZZeitview
Robotics and hardware
Series B+ · $55M$115MMar 4, 2025
round
AASAPP
AI agents
Series B+ · $120M$310MJan 7, 2025
Series B+
AA2 Biotherapeutics
Health and bio
Series B+ · $71.5M$270.5MJan 10, 2025
Series B+
TTriGemX Bio
Health and bio
backer$94MOct 1, 2026
round

Most frequent co-investors

Similar investors

Investors whose portfolios on Recent Funding center on the same category (Health and bio).

How this is counted

Share is of the 11 rounds on Recent Funding that name Euclidean Capital. Rounds with no announced date are left out of the year split, and "round" is a round whose stage is not on file.

Portfolio companies are the companies on Recent Funding with a round that lists Euclidean Capital, which is a subset of its real portfolio. API: /api/v1/investors/euclidean-capital (get a free API key). More: the most active VC firms and new venture capital funds.